NEUROSTAR RAPID TRANSCRANIAL MAGNETIC STIMULATION DEVICE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-11-05 for NEUROSTAR RAPID TRANSCRANIAL MAGNETIC STIMULATION DEVICE manufactured by Neuronetics Inc..

Event Text Entries

[126495543] Caller started using the neurostar rapid transcranial magnetic stimulation device in (b)(6) 2018, he had third-two treatment on this device; the last treatment was on (b)(6) 2018. He did not see any beneficial result instead he had headache, elevated anxiety and more depressed. He feels like he was left on the baseline of anxiety disorder. Caller stated that the therapeutic result is ineffective and the results is inadequate.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5081060
MDR Report Key8042005
Date Received2018-11-05
Date of Report2018-11-05
Date of Event2018-09-24
Date Added to Maude2018-11-06
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameNEUROSTAR RAPID TRANSCRANIAL MAGNETIC STIMULATION DEVICE
Generic NameNEUROSTAR TMS
Product CodeOBP
Date Received2018-11-05
Device Availability*
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerNEURONETICS INC.


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-11-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.